|
C10ORF118 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79112280562777E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.01070329462073E-11 |
| Normal-vs-Stage2 |
1.12560000209427E-08 |
| Normal-vs-Stage3 |
4.57649473872834E-11 |
| Normal-vs-Stage4 |
7.13279990627314E-10 |
| Stage1-vs-Stage2 |
3.555200E-01 |
| Stage1-vs-Stage3 |
2.579000E-01 |
| Stage1-vs-Stage4 |
1.469630E-01 |
| Stage2-vs-Stage3 |
9.338600E-01 |
| Stage2-vs-Stage4 |
6.716600E-01 |
| Stage3-vs-Stage4 |
5.733000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50988119177009E-12 |
| Normal-vs-AfricanAmerican |
1.019610E-03 |
| Normal-vs-Asian |
2.81250001066269E-09 |
| Caucasian-vs-AfricanAmerican |
3.035200E-01 |
| Caucasian-vs-Asian |
3.067400E-01 |
| AfricanAmerican-vs-Asian |
1.162000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34257058195908E-14 |
| Normal-vs-Female |
2.79239964484645E-11 |
| Male-vs-Female |
3.581900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44299996793518E-09 |
| Normal-vs-Age(41-60Yrs) |
3.87034848614576E-12 |
| Normal-vs-Age(61-80Yrs) |
3.56039642213091E-11 |
| Normal-vs-Age(81-100Yrs) |
1.782300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.204800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.134560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.879200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.475000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.652400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.569800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.828840E-01 |
| Classical-VS-Follicular |
2.027900E-02 |
| Classical-VS-Other |
1.227640E-01 |
| Classical-VS-Normal |
2.10560013869099E-10 |
| Tall-VS-Follicular |
8.585600E-01 |
| Tall-VS-Other |
3.320000E-01 |
| Tall-VS-Normal |
1.39159999967831E-07 |
| Follicular-VS-Other |
4.713400E-01 |
| Follicular-VS-Normal |
7.7242989782178E-11 |
| Other-VS-Normal |
2.364800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.75521877219398E-13 |
| Normal-vs-N1 |
4.78359996058941E-09 |
| N0-vs-N1 |
5.068000E-01 |
|
|
